Feasibility of transcatheter closure for absent aortic rim in patients with atrial septal defect

Catheter Cardiovasc Interv. 2021 Apr 1;97(5):859-864. doi: 10.1002/ccd.29457. Epub 2021 Jan 18.

Abstract

Objectives: This study aimed to assess the feasibility of transcatheter atrial septal defect (ASD) closure in patients with absent aortic rim.

Background: The indication of transcatheter closure for ASD with absent aortic rim is controversial.

Methods: We enrolled 547 patients with ASD who were scheduled for transcatheter closure. Morphologies of aortic rim were evaluated using transesophageal echocardiography (TEE).

Results: Aortic rim of <5 mm was observed in 396 (72%) patients; 128 (23%) had absent aortic rim of 0 mm, and 268 (49%) had deficient aortic rim of >0 to <5 mm. Patients with absent aortic rim frequently had aortic rim absence at an angle of 0° on TEE and septal malalignment. Of the 128 patients with absent aortic rim, 126 (98%) successfully underwent transcatheter closure, while 2 (2%) failed transcatheter closure due to a large defect with severe septal malalignment. The success rate of transcatheter closure was similar between patients with absent aortic rim and those with deficient aortic rim (98% vs. 99%, p = .45). After the procedure, no patients had erosion or device embolization during a median follow-up of 24 months.

Conclusions: Transcatheter closure was successfully performed without adverse events in patients with absent aortic rim, as well as in those with deficient aortic rim. Our findings can be valuable to determine the indication of transcatheter closure in patients with ASD.

Keywords: aortic rim; atrial septal defect; erosion; transcatheter closure.

MeSH terms

  • Cardiac Catheterization / adverse effects
  • Echocardiography, Transesophageal
  • Feasibility Studies
  • Heart Septal Defects, Atrial* / diagnostic imaging
  • Heart Septal Defects, Atrial* / therapy
  • Humans
  • Septal Occluder Device*
  • Treatment Outcome